The DOI matches its Crossref record.
Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.
Abstract
Dehydroepiandrosterone (DHEA), a major adrenal secretory steroid in humans, was therapeutic when fed in a concentration of 0.4% to C57BL/KsJ mice with either non-insulin-dependent or insulin-dependent diabetes. Genetically diabetic (db/db) mice of both sexes develop obesity and a glucose intolerance and hyperglycemia associated with insulin resistance by 2 mo of age, and exhibit beta-cell necrosis and islet atrophy by 4 mo. In contrast, DHEA feeding initiated between 1 and 4 mo of age, while only moderately effective in preventing obesity, did prevent the other pathogenic changes and effected a rapid remission of hyperglycemia, a preservation of beta-cell structure and function, and an increased insulin sensitivity as measured by glucose tolerance tests. DHEA feeding was also therapeutic to normal C57BL/KsJ male mice made diabetic by multiple low doses of streptozotocin (SZ). While DHEA treatments did not block either the direct cytotoxic action of SZ on beta-cells or the development of insulitis, the steroid significantly moderated the severity of the ensuing diabetes (reduced hyperglycemia and water consumption, and increased plasma insulin and numbers of residual, granulated beta-cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 70 -95% reduction in the formation of DHEA and DHEA-S by the adrenals during aging results in a dramatic reduction in the formation of androgens and estrogens in peripheral target tissues, which could well be involved in the pathogenesis of age-related diseases such as insulin resistance (307, 308) and obesity (309 -311).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [308]
Citations
Cited by
Sorted by citations
Quantitative and reproducible murine model of excisional wound healing
Galiano, R. D., Michaels, V. J., Dobryansky, M., Levine, J. P., & Gurtner, G. C. (2004) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2004.12404.x · Cited by 761
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
“The 70–95% reduction in the formation of DHEA and DHEA-S by the adrenals during aging results in a dramatic reduction in the formation of androgens and estrogens in peripheral target tissues, which could well be involved in the pathogenesis of age-related diseases such as insulin resistance (307, 308) and obesity (309…”
BackgroundAMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons
Claret, M., Smith, M. A., Batterham, R. L., Selman, C., Choudhury, A. I., Fryer, L. G. D., Clements, M., Al‐Qassab, H., Heffron, H., Xu, A. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31516 · Cited by 522
Is dehydroepiandrosterone a hormone?
Labrie, F., Luu-The, V., Bèlanger, A., Lin, S.-X., Simard, J., Pelletier, G., & Labrie, C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06264 · Cited by 460
“…in the formation of androgens and estrogens in peripheral target tissues, which could well be involved in the pathogenesis of age-related diseases such as insulin resistance (Coleman et al. 1982, Schriock et al. 1988) and obesity (Nestler et al. 1988, MacEwen & Kurzman 1991, Tchernof et al. 1995).”
BackgroundNESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Jung, U. J., Choi, M., Lee, M., & Jeong, K. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2499 · Cited by 370
Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0216 · Cited by 366
Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice
Zhao, H. J., Wang, S., Cheng, H., Zhang, M., Takahashi, T., Fogo, A. B., Breyer, M. D., & Harris, R. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070798 · Cited by 359
“In addition, when the db/db mutation is on the C57BLKS background, mice develop a late ( 4 mo) insulitis so that insulin levels are inappropriately low for the level of hyperglycemia (22).”
BackgroundLabrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Frank, S., Stallmeyer, B., Kämpfer, H., Kolb, N., & Pfeilschifter, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9148 · Cited by 301
Werner, S., Breeden, M. P., Hübner, G., Greenhalgh, D. G., & Longaker, M. T. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12395564 · Cited by 282
DHEA and peripheral androgen and estrogen formation: intracrinology
LABRIE, F., BÉLANGER, A., SIMARD, J., LUU‐THE, V., & LABRIE, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17369.x · Cited by 280
Labrie, F., Diamond, P., Cusan, L., Gomez, J.-L., Bélanger, A., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4306 · Cited by 292
Reduced expression of PDGF and PDGF receptors during impaired wound healing
Beer, H.-D., Longaker, M. T., & Werner, S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12319188 · Cited by 257
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
Casson, P. R., Andersen, R. N., Herrod, H. G., Stentz, F. B., Straughn, A. B., Abraham, G. E., & Buster, J. E. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90431-h · Cited by 211
The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells
Meikle, A. W., Dorchuck, R. W., Araneo, B. A., Stringham, J. D., Evans, T. G., Spruance, S. L., & Daynes, R. A. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90132-3 · Cited by 187
DHEA, Important Source of Sex Steroids in Men and Even More in Women
Labrie, F. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 187
“DHEA has been observed to induce hypogly caemia and anti-diabetic effects in animal models (Coleman et al., 1982; Coleman et al., 1984; McIntosh and Berdanier, 1991; Mukasa et al., 1998).”
BackgroundLoria, R. M., Inge, T. H., Cook, S. S., Szakal, A. K., & Regelson, W. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890260310 · Cited by 180
Development and application of rodent models for type 2 diabetes
Chen, D., & Wang, M. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00392.x · Cited by 180
Bologa, L., Sharma, J., & Roberts, E. R. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490170305 · Cited by 166
Novel mechanisms for DHEA action
Prough, R. A., Clark, B. J., & Klinge, C. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0013 · Cited by 163
“1977), diabetes (Coleman et al. 1982), and systemic lupus erythematosus (Lucas et al.”
BackgroundHigh-fat diet-induced muscle insulin resistance: relationship to visceral fat mass
Kim, J., Nolte, L. A., Hansen, P. A., Han, D., Ferguson, K., Thompson, P. A., & Holloszy, J. O. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.6.r2057 · Cited by 163
Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
Gordon, G. B., Shantz, L. M., & Talalay, P. (1987) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(87)90023-9 · Cited by 159
Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications
Wolkowitz, O. M., Epel, E. S., & Reus, V. I. (2001) · The World Journal of Biological Psychiatry · doi:10.3109/15622970109026799 · Cited by 151
“…peripheral catabolic effects of glucocorticoids by increasing sensitivity to insulin, enhancing adipocyte glucose uptake and diminishing hyperglycemia (Coleman et al 1982) and reducing adiposity (DongHo et al 1998), but similar effects have not been uniformly found in humans (Wellman et al 1999).”
BackgroundHerrington, D. M., Gordon, G. B., Achuff, S. C., Trejo, J. F., Weisman, H. F., Kwiterovich, P. O., & Pearson, T. A. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80334-1 · Cited by 147
Lucas, J. A., Ahmed, S. A., Casey, M. L., & MacDonald, P. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111929 · Cited by 145
Effects of ginseng saponins isolated from Red Ginseng roots on burn wound healing in mice
Kimura, Y., Sumiyoshi, M., Kawahira, K., & Sakanaka, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706794 · Cited by 144
Aragno, M., Brignardello, E., Tamagno, E., Gatto, V., Danni, O., & Boccuzzi, G. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1550233 · Cited by 140
“Three hours (but not 1 h) dehydroepiandrosterone-pretreatment protected tissues against lipid peroxidation induced by dextrose; both thiobarbituric acid reactive substances and hydroxynonenal adducts in liver, kidney and brain homogenates were significantly lower in…”
BackgroundDehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity
Schwartz, A. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2003.05.001 · Cited by 138
MIURA, T., ICHIKI, H., IWAMOTO, N., KATO, M., KUBO, M., SASAKI, H., OKADA, M., ISHIDA, T., SEINO, Y., & TANIGAWA, K. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.1009 · Cited by 137
Metabolism of DHEA in postmenopausal women following percutaneous administration
Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Chaussade, V., Castiel, I., et al. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.034 · Cited by 129
Dehydroepiandrosterone and Structural Analogs: A New Class of Cancer Chemopreventive Agents
Schwartz, A. G., Whitcomb, J. M., Nyce, J. W., Lewbart, M. L., & Pashko, L. L. (1988) · Advances in cancer research · doi:10.1016/s0065-230x(08)60227-4 · Cited by 126
Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans
Araghi‐Niknam, M., Chung, S., Nelson-White, T. M., Eskelson, C. D., & WATSON, R. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00396-7 · Cited by 128
Eich, D., Nestler, J. E., Johnson, D. E., Dworkin, G. H., Ko, D., Wechsler, A. S., & Hess, M. L. (1993) · Circulation · doi:10.1161/01.cir.87.1.261 · Cited by 126
Polyelectrolyte complex composed of chitosan and sodium alginate for wound dressing application
Kim, H.-J., Lee, H., Oh, J., Shin, B.-A., Oh, C.-S., Park, R., Yang, K., & Cho, C.-S. (1999) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856299x00478 · Cited by 125
Perrini, S., Natalicchio, A., Laviola, L., Belsanti, G., Montrone, C., Cignarelli, A., Minielli, V., Grano, M., Pergola, G. D., GIORGINO, R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.41 · Cited by 115
Schriock, E. D., Buffington, C. K., Hubert, G. D., Kurtz, B. R., Kitabchi, A. E., Buster, J. E., & Givens, J. R. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1329 · Cited by 115
Nestler, J. E., Usiskin, K., BARLASCINI, C. O., Welty, D. F., Clore, J. N., & Blackard, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-5-1040 · Cited by 115
Tomlinson, D. R., & Mayer, J. H. (1984) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1984.tb00434.x · Cited by 110
Advancing age and insulin resistance: new facts about an ancient history
Paolisso, G., Tagliamonte, Rizzo, M. R., & Giugliano, D. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00522.x · Cited by 112
Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians
Barbieri, M., Rizzo, M. R., Manzella, D., & Paolisso, G. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.178 · Cited by 112
“In animals, DHEAS administration improves glucose tolerance and insulin sensitivity allowing a decline in fasting plasma insulin concentrations [51,52].”
BackgroundDHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
Hansen, P. A., Han, D. H., Nolte, L. A., Chen, M. W., & Holloszy, J. O. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.5.r1704 · Cited by 110
“It has been reported that the 17-ketosteroid dehydroepiandrosterone (DHEA) reduces the accumulation of fat in various rodent models of obesity (3, 4, 7, 26, 32).”
BackgroundResultEndothelial dysfunction in the streptozotocin‐induced diabetic apoE‐deficient mouse
Ding, H., Hashem, M., Wiehler, W. B., Lau, W., Martín, J. M., Reid, J. J., & Triggle, C. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706417 · Cited by 107
Dehydroepiandrosterone and Diseases of Aging
WATSON, R. R., Huls, A., Araghinikuam, M., & Chung, S. (1996) · Drugs & Aging · doi:10.2165/00002512-199609040-00005 · Cited by 103
Plasma Dehydroepiandrosterone Sulfate in Nursing Home Men
Rudman, D. R., Shetty, K. R., & Mattson, D. E. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb03540.x · Cited by 100
The floating blueprint of hypothalamic feeding circuits
Horváth, T. L., & Diano, S. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1479 · Cited by 105
Inhibition of tumor development by dehydroepiandrosterone and related steroids.
Schwartz, A. G., Pashko, L., & Whitcomb, J. M. (1986) · Toxicologic Pathology · doi:10.1177/019262338601400312 · Cited by 101
Jansson, J.-H., Nilsson, T., & Johnson, O. (1998) · Heart · doi:10.1136/hrt.80.4.334 · Cited by 100
“Benefi-cial e V ects on lipids 15 and diabetes 16 in animal models have been found, suggesting an anti-atherogenic e V ect.”
BackgroundGreenhalgh, D. G. (2005) · Journal of Burn Care & Rehabilitation · doi:10.1097/01.bcr.0000169885.66639.b5 · Cited by 102
Dehydroepiandrosterone Research: Past, Current, and Future
Klinge, C. M., Clark, B. J., & Prough, R. A. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.02.002 · Cited by 97
Frenkel, R., Slaughter, C. A., Orth, K., Moomaw, C. R., Hicks, S. H., Snyder, J. M., Bennett, M., Prough, R. A., Putnam, R. S., & Milewich, L. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90293-2 · Cited by 91
Pannirselvam, M., Wiehler, W. B., Anderson, T. J., & Triggle, C. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706121 · Cited by 92
Callies, F., Faßnacht, M., van Vlijmen, J. C., Koehler, I., Huebler, D., Seibel, M. J., Arlt, W., & Allolio, B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7483 · Cited by 98
“Previous reports have shown that DHEA reduces body weight in rodents (1) and prevents diabetes mellitus in mice genetically predisposed to diabetes and obesity ( 2 , 3). However, the mice received DHEA in supraphysiological doses (e.g.”
BackgroundInsulin inhibits adrenal 17,20-lyase activity in man
Nestler, J. E., McClanahan, M. A., Clore, J. N., & Blackard, W. G. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.2.1730815 · Cited by 96
Therapeutic Effects of Dehydroepiandrosterone Metabolites in Diabetes Mutant Mice (C57BL/KsJ-db/db)*
Coleman, D., Leiter, E. H., & APPLEZWEIG, N. (1984) · Endocrinology · doi:10.1210/endo-115-1-239 · Cited by 92
Self-citationLiu, Y., Xu, H., Chen, S., Chen, X., Zhang, Z., Zhu, Z., Qin, X., Hu, L., Zhu, J. Z., Zhao, G., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001338 · Cited by 88
“T2D mouse model [31,32], in rats [33–35], and in humans [36].”
Acidic Fibroblast Growth Factor Accelerates Dermal Wound Healing in Diabetic Mice
Mellin, T. N., Cashen, D. E., Ronan, J., et al. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12607026 · Cited by 89
Gu, D., Nguyen, T., Gonzalez, A. M., Printz, M. A., Pierce, G. F., Sosnowski, B. A., Phillips, M. L., & Chandler, L. A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.018 · Cited by 87
“The diabetic (db/db) mouse exhibits characteristics of human adult onset diabetes, including impaired wound healing [26–28].”
BackgroundWu, H. Q., Masset-Brown, J., Tweedie, D., et al. (1989) · PubMed · Cited by 87
Sex Hormones and Macronutrient Metabolism
Comitato, R., Saba, A., Turrini, A., Arganini, C., & Virgili, F. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.651177 · Cited by 86
“Moreover, the external administration of 5-DHEA to genetically diabetic db–/db– mice induces the remission of hyperglycemia and improves insulin resistance (Coleman et al., 1982).”
BackgroundOkabe, T., Haji, M., Takayanagi, R., Adachi, M., Imasaki, K., Kurimoto, F., Watanabe, T., & Nawata, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559886 · Cited by 87
Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function
Yorek, M. A., Coppey, L. J., Gellett, J. S., Davidson, E. P., Bing, X., Lund, D. D., & Dillon, J. S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00173.2002 · Cited by 79
Dehydroepiandrosterone: antiglucocorticoid action in mice.
Browne, E. S., Wright, B. E., Porter, J. R., & Svec, F. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199206000-00003 · Cited by 77
Adrenal Androgen Secretion and Biologic Effects
Meikle, A. W., Daynes, R. A., & Araneo, B. A. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30274-3 · Cited by 76
Krampert, M., Kuenzle, S., Thai, S. N.-M., Lee, N., Iruela‐Arispe, M. L., & Werner, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412212200 · Cited by 76
Protective Effect of Dehydroepiandrosterone Against Copper-Induced Lipid Peroxidation in the Rat
Boccuzzi, G., Aragno, M., Seccia, M., Brignardello, E., Tamagno, E., Albano, E., Danni, O., & Bellomo, G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00543-6 · Cited by 75
SOWINSKASRZEDNICKA, J., Zgliczyński, S., Ciświcka-Sznajderman, M., Srzednicki, M., Soszynski, P. A., Biernacka, M., Woroszylska, M., RUZO, W., & SADOWSKI, Z. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90124-x · Cited by 74
Clark, I. A., Atwood, C., Bowen, R. L., Paz-Filho, G., & Vissel, B. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005850 · Cited by 76
“As might be expected from the interplay between reproductive hormones and TNF, sex steroids are well recognized to reverse post-SZT insulin resistance and protect from insulin resistance in rats exhibiting SZT-induced diabetes (Coleman et al., 1982; Ordonez et al., 2008).”
BackgroundZhang, L., Nair, A., Krady, K., Corpe, C. P., Bonneau, R. H., Simpson, I. A., & Vannucci, S. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18336 · Cited by 88
Hormonal Intervention: “Buffer Hormones” or “State Dependency”
Regelson, W., Loria, R. M., & Kalimi, M. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb35284.x · Cited by 75
Bhathena, S. J., Berlin, E., Judd, J., Kim, Y., Law, J., Bhagavan, H., Ballard-Barbash, R. R., & Nair, P. P. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.4.684 · Cited by 68
“(41, 45 , 53) and triglyceride (43, 54) and increases plasma and”
BackgroundIslet Cell Replication and Diabetes
Hellerström, C., Swenne, I., & Andersson, A. (1988) · Springer eBooks · doi:10.1007/978-3-642-72691-0_9 · Cited by 68
McNelis, J., Manolopoulos, K. N., Gathercole, L., Bujalska, I. J., Stewart, P. M., Tomlinson, J., & Arlt, W. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2012 · Cited by 66
Is dehydroepiandrosterone an antiobesity agent?
Berdanier, C. D., Parente, J. A., & McIntosh, M. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.5.8462783 · Cited by 66
DHEA Treatment Reduces Fat Accumulation and Protects Against Insulin Resistance in Male Rats
Han, D., Hansen, P. A., Chen, M. M., & Holloszy, J. O. (1998) · The Journals of Gerontology Series A · doi:10.1093/gerona/53a.1.b19 · Cited by 65
Liu, S., & Sun, Q. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12517 · Cited by 64
Menopausal obesity - myth or fact?
Milewicz, A., Tworowska, U., & Demissie, M. (2001) · Climacteric · doi:10.1080/cmt.4.4.273.283 · Cited by 81
Buster, J. E., Casson, P. R., Straughn, A. B., Dale, D., Umstot, E. S., Chiamori, N., & Abraham, G. E. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90602-4 · Cited by 62
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome
Brennan, K., Huang, A., & Azziz, R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.101 · Cited by 61
“Studies have shown improved glucose tolerance and insulin sensitivity with DHEAS supplementation in diabetic rodents (23).”
BackgroundInduction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
Ripp, S. L., Fitzpatrick, J. L., Peters, J. M., & Prough, R. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.570 · Cited by 60
“Administration of DHEA ameliorated symptoms of diabetes and systemic lupus erythematosis in the appropriate rodent models (Coleman et al., 1982; Lucas et al., 1985).”
BackgroundThe effect of 7-oxo-DHEA acetate on memory in young and old C57BL/6 mice
Shi, J., Schulze, S., & Lardy, H. A. (2000) · Steroids · doi:10.1016/s0039-128x(99)00094-x · Cited by 59
“Studies have shown that DHEA has a variety of physiological effects: it is an antiobesity agent in genetically obese and normal mice [2,3]; it normalizes blood sugar in diabetic mice [3–6]; it is anticarcinogenic [7–9]; and it enhances cellular immunity [10–12].”
BackgroundMetabolic alterations after dehydroepiandrosterone treatment in Zucker rats
Shepherd, A., & Cleary, M. P. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.2.e123 · Cited by 60
Immunochemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humans
Sharp, S., BARKER, E. V., Coughtrie, M. W. H., Lowenstein, P. R., & Hume, R. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17580.x · Cited by 58
DHEA improves glucose uptake via activations of protein kinase C and phosphatidylinositol 3-kinase
Ishizuka, T., Kajita, K., Miura, A., Ishizawa, M., Kanoh, Y., Itaya, S., Kimura, M., Muto, N., Mune, T., Morita, H., et al. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e196 · Cited by 58
Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia
Yamaguchi, Y., Tanaka, S., Yamakawa, T., et al. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00533.x · Cited by 58
Khalil, A., Fortin, J. P., Lehoux, J., & Fülöp, T. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31987-8 · Cited by 57
Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
Reifsnyder, P. C., Flurkey, K., Te, A. G., & Harrison, D. E. (2016) · Aging · doi:10.18632/aging.101117 · Cited by 57
Santos, C. D., Toldo, M. P. A., & Júnior, J. C. D. P. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.05.005 · Cited by 55
Topical Lineage-Negative Progenitor-Cell Therapy for Diabetic Wounds
Lin, C. D., Allori, A. C., Macklin, J. E., et al. (2008) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e318188217b · Cited by 54
Visfatin in human pregnancy: maternal gestational diabetesvis-à-visneonatal birthweight
Mazaki‐Tovi, S., Romero, R. J., Kusanovic, J. P., Vaisbuch, E., Erez, O., Than, N. G., Chaiworapongsa, T., Nhan‐Chang, C., Pacora, P., Gotsch, F., et al. (2008) · Journal of Perinatal Medicine · doi:10.1515/jpm.2009.053 · Cited by 53
Glucose, stress, and hippocampal neuronal vulnerability
Reagan, L. P. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51009-6 · Cited by 55
Amelioration of Insulin Resistance in Diabetes With Dehydroepiandrosterone
Buffington, C. K., Pourmotabbed, G., & Kitabchi, A. E. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199311000-00010 · Cited by 52
Brahimaj, A., Muka, T., Kavousi, M., Laven, J. S. E., Dehghan, A., & Franco, O. H. (2016) · Diabetologia · doi:10.1007/s00125-016-4136-8 · Cited by 51
“Previous studies in animal have documented therapeutic effects of DHEA in mice used as a model of diabetes [7].”
BackgroundCampbell, C. S. G., Caperuto, L. C., Hirata, A. E., ARAUJO, E. P. D., Velloso, L. A., Saad, M. J. A., & Carvalho, C. R. D. O. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.017 · Cited by 50
Physicochemical characterization of [3H] DHEA binding in rat liver
Kalimi, M., & Regelson, W. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80800-3 · Cited by 50
Leiter, E. H., Beamer, W. G., Coleman, D. L., & Longcope, C. (1987) · Metabolism · doi:10.1016/0026-0495(87)90095-3 · Cited by 50
Self-citationMetabolism of DHEA by Cytochromes P450 in Rat and Human Liver Microsomal Fractions
Fitzpatrick, J. L., Ripp, S. L., Smith, N. B., Pierce, W. M. J., & Prough, R. A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2341 · Cited by 50
DHEA administration and exercise training improves insulin resistance in obese rats
Sato, K., Iemitsu, M., Aizawa, K., Mesaki, N., Ajisaka, R., & Fujita, S. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-47 · Cited by 49
“Moreover, several reports demonstrated that shortterm (2 weeks) DHEA administration induced an acute decrease in blood glucose levels in mice [8,9], reduced serum insulin levels in older rats [2,10,11], and enhanced the activities of enzyme related to hepatic glucose metabolismin diet-induced or Zucker obese rats [12,…”
BackgroundEffect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity
Aoki, K., & Terauchi, Y. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.01.008 · Cited by 49
Metadata
- Authors
- Coleman, D. L., Leiter, E. H., & Schwizer, R. W.
- Affiliations
- Jackson Laboratory (US)
- ORCID
- Coleman, D L
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1982-09-01
- Volume
- 31
- Issue
- 9
- Pages
- 830-833
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1998106197
- Cited by
- 317
- References
- 0
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 7 · 2020: 2 · 2019: 2 · 2018: 4 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 3 · 2012: 8
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- dehydroepiandrosterone, type 2 diabetes, type 1 diabetes, db/db mice, streptozotocin-induced diabetes, insulin resistance, beta-cell function, beta cell necrosis, islet atrophy, hyperglycemia, impaired glucose tolerance, obesity, insulitis, plasma insulin, glucocorticoids
- MeSH terms
- Animals, Blood Glucose, Dehydroepiandrosterone, Diabetes Mellitus, Experimental, Female, Male, Mice, Inbred C57BL, Pancreas, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review